ClinConnect ClinConnect Logo
Search / Trial NCT04704817

Prospective Database for Colonic or Rectal Resection Surgery Patients

Launched by INSTITUT PAOLI-CALMETTES · Jan 8, 2021

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is set up to gather important information about patients who have undergone surgery for colon or rectal issues, particularly related to colorectal cancer. Colorectal cancer is a common type of cancer, affecting many men and women, and this study aims to learn more about the experiences and outcomes of patients after their surgeries.

To participate in this trial, you need to be at least 18 years old and have received treatment for colon or rectal surgery at the Paoli-Calmettes Institute. You also need to be part of a health insurance program. If you join the study, you’ll be contributing to valuable research that can help improve care for future patients. Although the trial is not yet recruiting participants, it's an important step in understanding how surgery impacts recovery and long-term health for those with colorectal disorders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients treated for colonic and / or rectal resection in the oncological digestive surgery department of the Paoli-Calmettes Institute,
  • 2. Patients over 18 years old,
  • 3. Affiliation to a social security scheme, or beneficiary of such a scheme.

About Institut Paoli Calmettes

Institut Paoli-Calmettes (IPC) is a leading cancer research and treatment center located in Marseille, France, dedicated to advancing oncology through innovative clinical trials and comprehensive patient care. With a multidisciplinary approach, IPC integrates cutting-edge research, education, and clinical services to enhance cancer prevention, diagnosis, and treatment. The institute is committed to fostering collaboration among researchers, healthcare professionals, and patients, aiming to translate scientific discoveries into effective therapeutic strategies. As a recognized institution in the field of oncology, IPC plays a pivotal role in shaping the future of cancer care and improving patient outcomes through rigorous and ethical clinical trials.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials